Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | PTGER1 | P34995 | 10/20 | 0.45 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8017055 | 0.87 | LMNA (0.68) | LMNAPTGER1PTGER3CYP1A2ALDH1A1 | |
| SCHEMBL17489117 | 0.83 | LMNA (0.47) | LMNAPTGER1PTGER3CYP1A2AURKA | |
| SCHEMBL2360638 | 0.81 | AURKA (0.60) | LMNAPTGER1PTGER3CYP1A2ALDH1A1 | |
| SCHEMBL26924222 | 0.80 | NPC1 (0.50) | LMNAPTGER1CYP1A2ALDH1A1 | |
| SCHEMBL13169989 | 0.80 | CYP1A2 (0.44) | LMNACYP1A2ALDH1A1AURKARPS6KB1 | |
| SCHEMBL7788141 | 0.79 | LMNA (0.72) | LMNACYP1A2ALDH1A1 | |
| SCHEMBL10274471 | 0.79 | AURKA (0.47) | LMNAPTGER1PTGER3AURKARPS6KB1 | |
| SCHEMBL10274473 | 0.76 | AURKA (0.41) | LMNAPTGER1PTGER3CYP1A2ALDH1A1 | |
| SCHEMBL10274612 | 0.76 | PTGER1 (0.43) | LMNAPTGER1PTGER3AURKARPS6KB1 | |
| SCHEMBL27740912 | 0.76 | KDM4E (0.51) | LMNAPTGER1PTGER3AURKARPS6KB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009096435-A1 | CONDENSED HETEROCYCLIC DERIVATIVES AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-08-06 | — | — | WO | disclosed |